http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1202626-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5929f2d6f4dba84be8dd3a8ba633db12 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
filingDate | 1983-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1986-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b92f2b95300101f155294eb099c73496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d160756efde62629ed6c5c89c786507 |
publicationDate | 1986-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-1202626-A |
titleOfInvention | Deazapurine derivatives |
abstract | Abstract 7-Deazapurine derivatives of the formula (I): (I) [R1 is an acyl group; each of R2 and R3 is an alkyl, alkenyl or aralkyl group or alternatively R2 and R3, taken together with the adjacent nitrogen atom, form a cyclic amino group, and each of said alkyl group a alkenyl group, aralkyl group and cyclic amino group has a methylene group in .alpha.-position]and salts thereof are of value as inter-mediates for the production of antitumor agents, biological reagents, etc. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6245903-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE39087-E |
priorityDate | 1982-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.